Earli

Programmable genetic constructs expressed only in cancer cells for targeted tumor killing

a16zActive

What they do

Problem

Current cancer therapies often lack specificity, leading to insufficient tumor killing and damage to healthy tissue.

Solution

It develops programmable genetic constructs that are selectively expressed in cancer cells to trigger targeted tumor cell killing.

Who it's for

Cancer patients treated by oncology clinicians and healthcare providers using targeted therapeutics.